Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05EBY
|
||||
Former ID |
DIB008329
|
||||
Drug Name |
PCSK9 Adnectin
|
||||
Synonyms |
PCSK9 Adnectin (cardiovascular); Adnectin program (cardiovascular disease), Adnexus/BMS; PCSK9 Adnectin (cardiovascular), Bristol-Myers Squibb
|
||||
Indication | Cardiovascular disorder [ICD10:I00-I99] | Phase 1 | [525391] | ||
Company |
Bristol-myers squibb
|
||||
Target and Pathway | |||||
Target(s) | Proprotein convertase subtilisin/kexin type 9 | Target Info | Modulator | [532837] | |
WikiPathways | PCSK9-mediated LDLR degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.